about
Genome-wide association study of bipolar disorder in European American and African American individualsGenetic relationship between five psychiatric disorders estimated from genome-wide SNPsGenome-wide association study of recurrent early-onset major depressive disorderA mega-analysis of genome-wide association studies for major depressive disorderMood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans.Serotonin polymorphisms and posttraumatic stress disorder in a trauma exposed African American populationBuprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.Diagnosing bipolar disorder in trauma exposed primary care patients.Overcoming barriers to reducing the burden of affective disorders.Ethnic minorities.Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants.Evidence for association of bipolar disorder to haplotypes in the 22q12.3 region near the genes stargazin, IFT27 and parvalbumin.Evidence of association between brain-derived neurotrophic factor gene and bipolar disorderCulturally adapted pharmacotherapy and the integrative formulation.Genetic and childhood trauma interaction effect on age of onset in bipolar disorder: An exploratory analysis.Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: A retrospective chart review.Trauma, resilience, and recovery in a high-risk African-American population.Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.Ethnic disparities in the perception of ethical risks from psychiatric genetic studies.Housing Experiences among Opioid-Dependent, Criminal Justice-Involved Individuals in Washington, D.C.Risperidone in the treatment of Hispanic inpatients with schizophrenia: a pilot study.Sleep paralysis and trauma, psychiatric symptoms and disorders in an adult African American population attending primary medical care.Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.Reducing disparities in mental health care: suggestions from the Dartmouth-Howard collaboration.Effects of divalproex on disruptive behavior of jail inmates.Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.Influence of patient race and ethnicity on clinical assessment in patients with affective disorders.Violence Research.The role of complex emotions in inconsistent diagnoses of schizophrenia.PTSD treatment of African American adults in primary care: the gap between current practice and evidence-based treatment guidelines.The psychiatric rehabilitation of African Americans with severe mental illness.Salt preference in desalivate rats.Sex differences in the use of healthcare services among US adults with and without a cancer diagnosis.Mental health of African Americans and Caribbean blacks in the United States: results from the National Epidemiological Survey on Alcohol and Related ConditionsPreliminary evidence of reduced combined output of dopamine and its metabolites in chronic schizophreniaEffects of consultation on the ward atmosphere in a state psychiatric hospitalRBC and plasma choline in neuroleptic-treated schizophrenic patientsIncreased urine volume in chronic schizophrenic patients
P50
Q24628870-D3BBB49C-88A8-4639-8F8D-E0E5492A63A4Q28296286-90C0634E-8961-4CB5-BA4D-C0C0EE65A560Q28943558-8F85C72A-342F-4886-9E64-CE7C8A9651EEQ29417093-E3AA31ED-ED16-43D4-90E5-0D43959BAAA1Q30473236-A4CB1B0B-C982-4761-8B6F-6E6E2025ABDFQ34235875-EFF969CC-DBAE-4638-9144-DCFCEA0CC2FAQ34517116-1A920606-9AC0-4D73-80BD-0E01DB5893D2Q34634147-3C137A0D-444C-4102-9FCF-A61C32714310Q34934394-F97FA037-C818-49E0-8E77-97389C9B4B61Q35056597-6440E18D-5C08-4E81-87B6-1129E83D3624Q36696173-2D1736F6-C124-4FA6-B865-5D46B7C12E41Q36880190-E99144F2-405B-450B-86E3-8A11F34E515EQ37123304-E65137A6-2F58-43BD-8609-408C7E58C3B1Q37807724-25501704-7290-48F4-8D34-E831FF960130Q38465062-D9E679D5-AD09-450F-95B1-DC4FD9DB9981Q38691415-E943840A-53D1-4C4B-95FA-FE41B786BC81Q39277120-44379817-93B6-4B3D-A658-B003BE231F64Q39732399-8444F90A-1928-4E9F-8D6E-E34C343F83B9Q39748641-92C85E6C-5ED5-4127-8A24-2D2EB2F9C62CQ40183241-FC7E5571-25A9-4339-ADE9-981CF6C08722Q44279814-B3816899-09E1-4079-AF5B-D9B978FEC029Q44428583-1408B4AE-23C1-4C27-971D-514C539807C4Q44674061-312B8F8D-97E0-4766-8F7F-37EA6FE65CB2Q44684784-DD12763E-36E7-410C-851A-A920069CA15AQ45334965-7864865A-A36F-4F0F-8501-7330E79786A3Q46153422-5749E194-180E-404C-9BC6-733C6421BA90Q46869527-6CC4DC09-0AA1-4F0F-ABBF-5AB593703ECFQ48349533-CBDB5914-4736-4D6B-9E30-1B1EAD6E1DA2Q48737074-6BC83193-9291-4D3B-B627-67D206C6E1BEQ49649999-46EA7E6F-A55C-457E-85A5-793B834E1D3BQ50669465-CE6C65EE-C0DC-473B-9D77-C7D523F2F2F4Q50783421-8CB24F98-E95C-4910-AEEB-BCDAAED97EDFQ51851804-A89DC635-A220-41BC-9672-6C374AFFE9CEQ53788555-EB91A08E-B46E-48E7-88BA-F54A9D558626Q55385589-9584199D-0150-485E-A452-D102E23083B6Q60447018-FE6EC3EB-80CD-4156-899C-18D286EB41C1Q68998453-EB82A925-F2BD-46F1-B124-E07DA05B4CDDQ69039370-F4E2D086-A439-4BA2-A79D-FE4532B02897Q69373473-8DAF612D-6792-4D09-A833-634D85641176Q69841898-FECC6381-AE7B-445C-9CE8-36C479B97C26
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
William B Lawson
@nl
William B Lawson
@sl
William B. Lawson
@en
William B. Lawson
@es
type
label
William B Lawson
@nl
William B Lawson
@sl
William B. Lawson
@en
William B. Lawson
@es
altLabel
William Lawson
@en
prefLabel
William B Lawson
@nl
William B Lawson
@sl
William B. Lawson
@en
William B. Lawson
@es
P1053
O-9758-2017
P106
P1153
36916742600
P21
P31
P3829
P496
0000-0002-9324-7090